Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Sees Significant Drop in Short Interest

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) was the recipient of a significant decline in short interest during the month of October. As of October 15th, there was short interest totaling 67,594 shares, a decline of 41.3% from the September 30th total of 115,090 shares. Based on an average daily volume of 3,118,131 shares, the short-interest ratio is presently 0.0 days. Approximately 0.1% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Zhengye Biotechnology in a research report on Friday, October 16th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Zhengye Biotechnology Stock Performance

ZYBT stock traded down $0.13 during midday trading on Friday, reaching $1.30. The company had a trading volume of 122,913 shares, compared to its average volume of 1,753,646. The stock has a 50 day moving average price of $1.48 and a 200 day moving average price of $1.16. Zhengye Biotechnology has a fifty-two week low of $0.62 and a fifty-two week high of $8.01.

About Zhengye Biotechnology

Zhengye Biotechnology Group Co, Ltd. is a China-based biotechnology company focused on developing, manufacturing and selling biological products for the agricultural and animal husbandry industries. Its business is centered on applying microbial technologies to support animal health, livestock production and crop cultivation.

The company’s product offerings include microbial-based products used in animal feed and agricultural production, as well as related biological solutions intended to improve farming efficiency and promote healthier livestock and crops.